Se acerca la temporada de lluvias: alerta por dengue: cómo las empresas de diagnóstico in vitro pueden conquistar el mercado del sudeste asiático con láminas de oro coloidal sin cortar.

15-04-2026

Southeast Asia is in the dry-to-rainy transition in April, with the Indochina Peninsula to enter the main rainy season (May-October). According to WHO Western Pacific Region and local health departments, Vietnam reported 27,365 dengue cases and Malaysia 14,316 cases from Jan to Mar, with significant year-on-year increases. The epidemic peak is expected in May-June, driving a surge in rapid testing demand.

dengue fever

Source from WHO Dengue Situation Update 742, Malaysia

For local IVD enterprises, April is the golden window for raw material stocking. Colloidal gold immunochromatography is the mainstream local detection method, and high-quality colloidal gold uncut sheets are key to rapid market response.

In response to the prevention and control scenarios of dengue fever and the surging testing demand in Southeast Asia, WIZBIOTECH launches two core colloidal gold uncut sheets products – Dengue NS1 Antigen Rapid Test Colloidal Gold Uncut Sheets and Dengue IgM/IgG Antibody Rapid Test Colloidal Gold Uncut Sheets. The two products can be used independently or in combination, both with the core advantages of high accuracy, strong adaptability and ready-to-produce convenience, providing a one-stop raw material solution for IVD enterprises. They are especially suitable for enterprises that have product registration certificates, slitting equipment but no actual R&D and production capabilities, helping them quickly put into production and seize the market. 

1. Dengue NS1 Antigen Rapid Test Colloidal Gold Uncut Sheets: Focus on Rapid Detection in the Acute Phase

This product is specially designed for the detection of the acute phase of dengue fever, with the core function of realizing early screening of the epidemic, helping to quickly identify infected persons and block transmission:

Core Advantage: NS1 antigen can be detected as early as 0-5 days after the onset of the acute phase, enabling early detection and diagnosis of dengue fever, and striving for a golden window for severe case prevention and control;

2. Dengue IgM/IgG Antibody Rapid Test Colloidal Gold Uncut Sheets: Focus on Infection Stage and Immune Status Judgment

This product focuses on distinguishing the stage of dengue fever infection and judging the immune status, providing support for clinical diagnosis and epidemic traceability. The raw materials have been strictly verified in multiple batches, and various indicators are better than the industry average:

IgM Antibody Detection: Appears 3-5 days after the onset, clearly indicating current infection, and providing direct basis for clinical treatment;

IgG Antibody Detection: Appears 1 week after the onset, which can distinguish primary infection from secondary infection and provide early warning of severe risk;

High Specificity: No cross-reaction with similar arboviruses such as yellow fever and Zika virus, ensuring the accuracy of diagnosis. 

Common Advantages

  • Listo para la producción: Corte directo para la producción sin I+D ni depuración, lo que acorta el ciclo de lanzamiento;

  • Adaptable a diferentes escenarios: compatible con sangre entera/suero/plasma, resultados en 10-15 minutos, sin necesidad de equipo profesional;

  • Estable: almacenamiento entre 2 y 30 ℃ (sin cadena de frío), pequeñas variaciones entre lotes.

Sugerencias de diseño básico para empresas de diagnóstico in vitro (IVD)

  • Abastézcase con antelación: Abastezcase de las dos hojas sin cortar en abril para satisfacer la demanda máxima que se producirá entre mayo y junio durante la epidemia.

  • Diseño flexible: utilice un solo producto o una combinación de ellos para lograr una detección completa del recorrido y una diferenciación de formas.

  • Centrarse en las regiones de alto riesgo: desplegarse en Vietnam, Malasia e Indonesia, personalizar los planes de promoción y acelerar el registro local.

La próxima temporada de lluvias ofrece grandes oportunidades para las empresas de diagnóstico in vitro. Nuestras dos láminas de oro coloidal sin cortar, con ventajas de alta precisión y listas para usar, ayudan a las empresas a responder rápidamente a la demanda del mercado y lograr un beneficio mutuo entre el desarrollo y la protección de la salud pública.

Obtenga el último precio? Le responderemos lo antes posible (dentro de las 12 horas)

Política de privacidad